Literature DB >> 24508934

Neuropsychiatric symptoms and rehabilitation outcomes in patients with hip fracture.

Bernardo Gialanella1, Paola Prometti, Vittoria Monguzzi, Cristina Ferlucci.   

Abstract

OBJECTIVE: The aim of this study was to determine the association between functional recovery and neuropsychiatric symptoms in hip fracture patients undergoing in-hospital rehabilitation. Very few studies have extensively evaluated neuropsychiatric symptoms in hip fracture patients, and the relationship between these symptoms and rehabilitation outcome is not yet clearly defined.
DESIGN: This study was conducted on 200 patients with hip fracture who underwent a rehabilitation program. The Neuropsychiatric Inventory was used to identify neuropsychiatric symptoms. Efficiency and effectiveness in terms of the motor-Functional Independence Measure and length of stay were considered as outcome measures.
RESULTS: At admission, 74% of the patients had neuropsychiatric symptoms. At the end of rehabilitation, the patients with neuropsychiatric symptoms had a lower motor-Functional Independence Measure effectiveness (P = 0.015) and efficiency (P = 0.002) and a longer length of stay (P = 0.008) than those without neuropsychiatric symptoms. However, after adjustment for the Mini-Mental State Examination, the patients with neuropsychiatric symptoms differed from those without symptoms only in terms of longer length of stay (P = 0.006) and lower motor-Functional Independence Measure efficiency (P = 0.008).
CONCLUSIONS: Neuropsychiatric symptoms make the rehabilitation process slower and less efficient in hip fracture patients. Understanding the relationship between neuropsychiatric symptoms and outcome may be useful to physicians for the management of hip fracture patients.

Entities:  

Mesh:

Year:  2014        PMID: 24508934     DOI: 10.1097/PHM.0000000000000062

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  7 in total

1.  Late-Life Depressive and Anxiety Symptoms Following Rehabilitation Services in Medicare Beneficiaries.

Authors:  Adam Simning; Julie Kittel; Yeates Conwell
Journal:  Am J Geriatr Psychiatry       Date:  2018-12-13       Impact factor: 4.105

2.  Relationship between Functional Improvement and Cognition in Short-Stay Nursing Home Residents.

Authors:  Lacey Loomer; Brian Downer; Kali S Thomas
Journal:  J Am Geriatr Soc       Date:  2018-12-13       Impact factor: 5.562

3.  A Guide to Improving the Care of Patients with Fragility Fractures, Edition 2.

Authors:  Simon C Mears; Stephen L Kates
Journal:  Geriatr Orthop Surg Rehabil       Date:  2015-06

4.  Association of functional polymorphisms from brain-derived neurotrophic factor and serotonin-related genes with depressive symptoms after a medical stressor in older adults.

Authors:  Kerri S Rawson; David Dixon; Petra Nowotny; William M Ricci; Ellen F Binder; Thomas L Rodebaugh; Leah Wendleton; Peter Doré; Eric J Lenze
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

5.  Handgrip strength is an independent predictor of functional outcome in hip-fracture women: a prospective study with 6-month follow-up.

Authors:  Marco Di Monaco; Carlotta Castiglioni; Elena De Toma; Luisa Gardin; Silvia Giordano; Rosa Tappero
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

6.  Handgrip strength: a reliable predictor of postoperative early ambulation capacity for the elderly with hip fracture.

Authors:  Chih-Mai Chang; Cheng-Hung Lee; Cheng-Min Shih; Shun-Ping Wang; Yung-Cheng Chiu; Cheng-En Hsu
Journal:  BMC Musculoskelet Disord       Date:  2021-01-22       Impact factor: 2.362

7.  Executive Function Moderates Functional Outcomes of Engagement Strategies During Rehabilitation in Older Adults.

Authors:  Baris Ercal; Thomas L Rodebaugh; Marghuretta D Bland; Peggy Barco; Emily Lenard; Catherine E Lang; J Philip Miller; Michael Yingling; Eric J Lenze
Journal:  Am J Phys Med Rehabil       Date:  2021-07-01       Impact factor: 3.412

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.